The Pharmacy Quality Alliance (PQA) - Chain Drug Review

Skip to content

MMR Sign In Subscribe

PQA endorses one quality measure and retires three quality measures

Pharmacy

PQA endorses one quality measure and retires three quality measures

The newly endorsed measure, Chronic Obstructive Pulmonary Disease Treatment Ratio (CTR), evaluates the percentage of individuals 40 years of age or older whose Chronic Obstructive Pulmonary Disease (COPD) Treatment Ratio (CTR) is least 70 percent during the treatment period.

, and CDR

October 17, 2025

Pharmacy Quality Alliance elects 2025 board of directors and executive committee

Pharmacy

Pharmacy Quality Alliance elects 2025 board of directors and executive committee

Four new members from diverse health care professions, organizations and industries join board.

, and CDR

January 27, 2025

Recommendations for advancing health equity with PQA quality measures detailed in new report

Pharmacy

Recommendations for advancing health equity with PQA quality measures detailed in new report

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.

, and CDR

December 20, 2024

PQA evaluating pharmacy impact on immunization assessment and gap closure

Pharmacy

PQA evaluating pharmacy impact on immunization assessment and gap closure

Pilot will evaluate measure concepts and data exchange in value-based arrangements.

, and CDR

September 24, 2024